What it sells
Developing milk-inspired therapeutics for infectious diseases
Business model breakdown
Workflow: what inputs become what output?
AI-enabled platform identifies antimicrobial peptides from mammalian milk, developed as topical therapeutics; UC Davis spin-off.
Economics: what it saves and how it charges
UnverifiedPre-revenue therapeutics developer; grants page suggests grant funding.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2021 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.